Interim report Q2 2025

Bactiguard Holding AB (publ) published its interim report for the second quarter on Tuesday 15th July 2025 at 07:00 CET.

In connection with this, Bactiguard will host an audiocast for investors, analysts, and media at 11:00 CET. CEO Christine Lind will present the report and answer questions together with CFO Patrick Bach

To the report Report PDF Presentation
Annual and Sustainability Report 2024

Annual and Sustainability Report 2024

To the Annual and Sustainability Report 2024 Annual and Sustainability Report 2024 PDF

Updated strategic and financial targets

Bactiguard Holding AB (publ.) has announced its updated strategic and financial targets following a review announced in connection with the 2024 Q3 report. The updated targets reflect a sharpened strategic focus on the license business and EBITDA profitability, a transformation delivered in 2024.

Presentation (PDF) Read more

The Bactiguard Technology

The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.

Learn more about the technology

Purpose

To champion a healthier world by preventing infections.

Vision

To be the global standard of care for preventing medical device related infections.

Mission

To be the premier partner for leading MedTech companies, joining forces to redefine healthcare and improve health worldwide.

Core values

  • Respect
  • Trust
  • Transparency
  • Performance

Bactiguard is a purpose-driven company with a strong corporate culture, firmly anchored in four core values. The values are an integral part of Bactiguard’s purpose to champion a healthier world by preventing infections and a prerequisite to achieve our targets.

Press releases

All press releases

The share

Bactiguard as an investment

The ambition is to become a profitable knowledge and specialist organization which is a prerequisite to deliver on our financial, strategic and sustainability targets.

Three reasons to invest in Bactiguard

Calendar
  • 01
    Sep 2025

    Bactiguard presents at DNB Carnegie’s Small Cap Day

  • 16
    Sep 2025

    Bactiguard presents at Pareto Securities’ 16 Annual Healthcare Conference 2025

  • 23
    Oct 2025

    Interim report third quarter 1 July – 30 September 2025

Media & Investor Relations

  • Nina Nornholm

    Nina Nornholm

    Executive Vice President Communications & Investor Relations

    +46 70 855 0356